Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04493619
Title PLX2853 as a Single Agent in Advanced Gynecological Malignancies and in Combination With Carboplatin in Platinum-Resistant Epithelial Ovarian Cancer
Recruitment Terminated
Gender female
Phase Phase Ib/II
Variant Requirements No
Sponsors Plexxikon
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | CAN

Facility Status City State Zip Country Details
The University of Chicago Medical Center Chicago Illinois 05841 United States Details
Massachusetts General Hospital Boston Massachusetts 02114 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
University of Oklahoma - Stephenson Cancer Center Oklahoma City Oklahoma 73104 United States Details
Tennessee Oncology / Sarah Cannon Nashville Tennessee 37203 United States Details
University of Virginia Health Systems Charlottesville Virginia 22908 United States Details
Virginia Cancer Specialists, PC Fairfax Virginia 22031 United States Details
University of Washington / Seattle Cancer Care Alliance Seattle Washington 98109 United States Details
Princess Margaret Cancer Centre Toronto Ontario Canada Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field